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Wischmeyer et al. recently reported the promising re-
sults of their TOP-UP pilot trial [1]. This letter aims at
clarifying a semantic problem which has complicated the
interpretation of many studies. The authors’ hypothesis
was that supplemental parenteral nutrition (SPN)
combined with enteral nutrition (EN) in ICU patients
would improve 60-day survival: 125 patients on mechan-
ical ventilation for acute respiratory failure were enrolled
“within 3 days”. Patients were on EN or EN + SPN to
reach 100% of the prescribed energy target, which was
25 or 20 kcal/kg actual body weight (BW) for BMI < 25
or > 35, respectively.
EN was initiated at 20 ml/h and progressively increased
until the calculated energy target was reached. SPN was
administered to complete the energy needs up to the
energy target. Intervention was continued for 7 days.
When we proposed the SPN concept [2], the idea was
to first test the patient’s tolerance to EN, as many can
meet their energy needs by day 3. For those unable to
reach their energy needs, SPN was proposed to cover
100% of energy needs measured by indirect calorimetry.
In other words, SPN aims at rescuing situations where
EN fails to cover measured needs. The beneficial impact
of SPN with regards to noscomial infections in 305
patients supported the concept [3].
SPN was used in the TOP-UP trial for other reasons:
1. Additional SPN was administered within 3 days
(timing not clear either) without evidence of EN
intolerance.
2. Energy needs were calculated (not measured) based
on actual BW, not considering fluid overload,
sarcopenia, or adiposity. In patients with BMI > 35,
20 kcal/kg is likely to have resulted in serious
overfeeding, a condition known to jeopardize the
clinical outcome. Of note, the American Society for
Parenteral and Enteral Nutrition (ASPEN)
recommends 10–14 kcal/kg.
3. The full energy target was reached by day 1 in the
TOP-UP group, a condition likely to result in
overfeeding because of the endogenous production
of energy during the early phase in the ICU [4].
In summary, the authors used the term SPN for an
intervention clearly different from the original definition.
Indeed, they tested an “early full feeding” strategy,
potentially harmful without measurement of energy
needs, instead of a delayed SPN from day 4 based on
measured needs. This does not reduce the value of their
results, but certainly increases confusion among the
medical community. We would encourage the use of the
term “supplemental parenteral nutrition” only in studies
where the technical criteria of SPN are applied.
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